Salivary Flow Rate in Patients with Sjögren’s Syndrome: Correlations with Salivary Gland Ultrasound Findings and Biomarkers of Disease Activity
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
4.1. Patient Selection
4.2. Focus Score Assessment
4.3. Salivary Gland Ultrasonography (SGUS)
4.4. Investigation of Salivary Flow Rate
4.5. Statistical Analysis
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Strand, V.; Talal, N. Advances in the diagnosis and concept of Sjögren’s syndrome (autoimmune exocrinopathy). Bull. Rheum. Dis. 1979, 30, 1046–1052. [Google Scholar]
- Psianou, K.; Panagoulias, I.; Papanastasiou, A.D.; de Lastic, A.-L.; Rodi, M.; Spantidea, P.I.; Degn, S.E.; Georgiou, P.; Mouzaki, A. Clinical and immunological parameters of Sjögren’s syndrome. Autoimmun. Rev. 2018, 17, 1053–1064. [Google Scholar] [CrossRef] [PubMed]
- Qin, B.; Wang, J.; Yang, Z.; Yang, M.; Ma, N.; Huang, F.; Zhong, R. Epidemiology of primary Sjögren’s syndrome: A systematic review and meta-analysis. Ann. Rheum. Dis. 2015, 74, 1983–1989. [Google Scholar] [CrossRef] [PubMed]
- Nocturne, G.; Mariette, X. Sjögren Syndrome-associated lymphomas: An update on pathogenesis and management. Br. J. Haematol. 2015, 168, 317–327. [Google Scholar] [CrossRef] [PubMed]
- Thurtle, E.; Grosjean, A.; Steenackers, M.; Strege, K.; Barcelos, G.; Goswami, P. Epidemiology of Sjögren’s: A Systematic Literature Review. Rheumatol. Ther. 2024, 11, 1–17. [Google Scholar] [CrossRef] [PubMed]
- Christodoulou, M.I.; Kapsogeorgou, E.K.; Moutsopoulos, H.M. Characteristics of the minor salivary gland infiltrates in Sjögren’s syndrome. J. Autoimmun. 2010, 34, 400–407. [Google Scholar] [CrossRef] [PubMed]
- Yeung, C.K.; Wong, K.L.; Wong, W.S.; Chan, K.H. beta 2-Microglobulin and systemic lupus erythematosus. J. Rheumatol. 1986, 13, 1053–1058. [Google Scholar]
- Yang, J.; Qian, J.; Wezeman, M.; Wang, S.; Lin, P.; Wang, M.; Yaccoby, S.; Kwak, L.W.; Barlogie, B.; Yi, Q. Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies. Cancer Cell 2006, 10, 295–307. [Google Scholar] [CrossRef]
- Pertovaara, M.; Korpela, M.; Uusitalo, H.; Pukander, J.; Miettinen, A.; Helin, H.; Pasternack, A. Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both). Ann. Rheum. Dis. 1999, 58, 423. [Google Scholar] [CrossRef] [PubMed]
- Tecer, D.; Büyükşireci, D.; Günendi, Z.; Göğüş, F. The association of serum beta-2-microglobulin with autoantibody production and disease activity in patients with primary Sjogren’s syndrome. Gulhane Med. J. 2020, 62, 272–277. [Google Scholar] [CrossRef]
- Tian, Y.; Yang, H.; Liu, N.; Li, Y.; Chen, J. Advances in Pathogenesis of Sjögren’s Syndrome. J. Immunol. Res. 2021, 2021, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Sebastian, A.; Madej, M.; Gajdanowicz, P.; Sebastian, M.; Łuczak, A.; Zemelka-Wiącek, M.; Jutel, M.; Wiland, P. Interferon Gamma Targeted Therapy: Is It Justified in Primary Sjögren’s Syndrome? J. Clin. Med. 2022, 11, 5405. [Google Scholar] [CrossRef] [PubMed]
- Roescher, N.; Tak, P.P.; Illei, G.G. Cytokines in Sjögren’s syndrome: Potential therapeutic targets. Ann. Rheum. Dis. 2010, 69, 945. [Google Scholar] [CrossRef]
- Cenerenti, M.; Saillard, M.; Romero, P.; Jandus, C. The Era of Cytotoxic CD4 T Cells. Front. Immunol. 2022, 13, 867189. [Google Scholar] [CrossRef] [PubMed]
- Mosmann, T.R.; Cherwinski, H.; Bond, M.W.; Giedlin, M.A.; Coffman, R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986, 136, 2348–2357. [Google Scholar] [CrossRef] [PubMed]
- Youinou, P.; Pers, J.O. Disturbance of cytokine networks in Sjögren’s syndrome. Arthritis Res. Ther. 2011, 13, 227. [Google Scholar] [CrossRef] [PubMed]
- Costa, S.; Quintin-Roué, I.; Lesourd, A.; Jousse-Joulin, S.; Berthelot, J.-M.; Hachulla, E.; Hatron, P.-Y.; Goeb, V.; Vittecoq, O.; Pers, J.O.; et al. Reliability of histopathological salivary gland biopsy assessment in Sjögren’s syndrome: A multicentre cohort study. Rheumatology 2015, 54, 1056–1064. [Google Scholar] [CrossRef] [PubMed]
- Fisher, B.A.; Jonsson, R.; Daniels, T.; Bombardieri, M.; Brown, R.M.; Morgan, P.; Bombardieri, S.; Ng, W.-F.; Tzioufas, A.G.; Vitali, C.; et al. Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann. Rheum. Dis. 2017, 76, 1161–1168. [Google Scholar] [CrossRef]
- Lorenzon, M.; Spina, E.; Di Franco, F.T.; Giovannini, I.; Zabotti, A.; De Vita, S. Salivary Gland Ultrasound in Primary Sjögren’s Syndrome: Current and Future Perspectives. Open Access Rheumatol. 2022, 14, 147–160. [Google Scholar] [CrossRef] [PubMed]
- Hočevar, A.; Rainer, S.; Rozman, B.; Zor, P.; Tomšič, M. Ultrasonographic changes of major salivary glands in primary Sjögren’s syndrome. Eur. J. Radiol. 2007, 63, 379–383. [Google Scholar] [CrossRef]
- Cornec, D.; Jousse-Joulin, S.; Pers, J.; Marhadour, T.; Cochener, B.; Boisramé-Gastrin, S.; Nowak, E.; Youinou, P.; Saraux, A.; Devauchelle-Pensec, V. Contribution of salivary gland ultrasonography to the diagnosis of Sjögren’s syndrome: Toward new diagnostic criteria? Arthritis Rheum. 2013, 65, 216–225. [Google Scholar] [CrossRef]
- Takagi, Y.; Sumi, M.; Nakamura, H.; Iwamoto, N.; Horai, Y.; Kawakami, A.; Nakamura, T. Ultrasonography as an additional item in the American College of Rheumatology classification of Sjögren’s syndrome. Rheumatology 2014, 53, 1977–1983. [Google Scholar] [CrossRef] [PubMed]
- Kohler, P.F.; Winter, M.E. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum. 1985, 28, 1128–1132. [Google Scholar] [CrossRef] [PubMed]
- Shizukuishi, K.; Nagaoka, S.; Kinno, Y.; Saito, M.; Takahashi, N.; Kawamoto, M.; Abe, A.; Jin, L.; Inoue, T. Scoring analysis of salivary gland scintigraphy in patients with Sjögren’s syndrome. Ann. Nucl. Med. 2003, 17, 627–631. [Google Scholar] [CrossRef]
- Triantafyllias, K.; Bach, M.; Otto, M.; Schwarting, A. Diagnostic Value of Labial Minor Salivary Gland Biopsy: Histological Findings of a Large Sicca Cohort and Clinical Associations. Diagnostics 2023, 13, 3117. [Google Scholar] [CrossRef]
- Fox, R.I. Sjögren’s syndrome. Lancet 2005, 366, 321–331. [Google Scholar] [CrossRef] [PubMed]
- Goules, A.V.; Tzioufas, A.G. Primary Sjögren’s syndrome: Clinical phenotypes, outcome and the development of biomarkers. Immunol. Res. 2017, 65, 331–344. [Google Scholar] [CrossRef]
- Singh, G.; Singh, S.; Matteson, E.L. Rate, risk factors and causes of mortality in patients with Sjögren’s syndrome: A systematic review and meta-analysis of cohort studies. Rheumatology 2016, 55, 450–460. [Google Scholar] [CrossRef]
- De Vita, S.; Lorenzon, G.; Rossi, G.; Sabella, M.; Fossaluzza, V. Salivary gland echography in primary and secondary Sjögren’s syndrome. Clin. Exp. Rheumatol. 1992, 10, 351–356. [Google Scholar]
- Zabotti, A.; Callegher, S.Z.; Gandolfo, S.; Valent, F.; Giovannini, I.; Cavallaro, E.; Lorenzon, M.; De Vita, S. Hyperechoic bands detected by salivary gland ultrasonography are related to salivary impairment in established Sjögren’s syndrome. Clin. Exp. Rheumatol. 2019, 37, S146–S152. [Google Scholar]
- Ramos-Casals, M.; Font, J. Primary Sjögren’s syndrome: Current and emergent aetiopathogenic concepts. Rheumatology 2005, 44, 1354–1367. [Google Scholar] [CrossRef]
- Pijpe, J.; Kalk, W.W.I.; Bootsma, H.; Spijkervet, F.K.L.; Kallenberg, C.G.M.; Vissink, A. Progression of salivary gland dysfunction in patients with Sjogren’s syndrome. Ann. Rheum. Dis. 2007, 66, 107–112. [Google Scholar] [CrossRef] [PubMed]
- Fasano, S.; Mauro, D.; Macaluso, F.; Xiao, F.; Zhao, Y.; Lu, L.; Guggino, G.; Ciccia, F. Pathogenesis of primary Sjögren’s syndrome beyond B lymphocytes. Clin. Exp. Rheumatol. 2020, 38, S315–S323. [Google Scholar]
- Zandonella Callegher, S.; Giovannini, I.; Zenz, S.; Manfrè, V.; Stradner, M.H.; Hocevar, A.; Gutierrez, M.; Quartuccio, L.; De Vita, S.; Zabotti, A. Sjögren syndrome: Looking forward to the future. Ther. Adv. Musculoskelet. Dis. 2022, 14, 1759720X221100295. [Google Scholar] [CrossRef] [PubMed]
- Chen, C.; Liang, Y.; Zhang, Z.; Zhang, Z.; Yang, Z. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren’s syndrome. Int. Immunopharmacol. 2020, 88, 106878. [Google Scholar] [CrossRef] [PubMed]
- Jonsson, R.; Theander, E.; Sjos, B.; Brokstad, K.; Henriksson, G. Autoantibodies present before symptom onset in primary Sjögren syndrome. JAMA 2013, 310, 1854–1855. [Google Scholar] [CrossRef] [PubMed]
- Theander, E.; Jonsson, R.; Sjöström, B.; Brokstad, K.; Olsson, P.; Henriksson, G. Prediction of Sjögren’s Syndrome Years Before Diagnosis and Identification of Patients with Early Onset and Severe Disease Course by Autoantibody Profiling. Arthritis Rheumatol. 2015, 67, 2427–2436. [Google Scholar] [CrossRef] [PubMed]
- Shang, L.; He, L.; Li, M. What exactly is the relationship between plasma cytokines and the clinical phenotype of primary sjögren’s syndrome? a single-centre retrospective study. Int. Immunopharmacol. 2023, 122, 110567. [Google Scholar] [CrossRef] [PubMed]
- Li, L.; Dong, M.; Wang, X.G. The Implication and Significance of Beta 2 Microglobulin: A Conservative Multifunctional Regulator. Chin. Med. J. 2016, 129, 448. [Google Scholar] [CrossRef] [PubMed]
- Yoo, C.; Yoon, D.H.; Suh, C. Serum beta-2 microglobulin in malignant lymphomas: An old but powerful prognostic factor. Blood Res. 2014, 49, 148–153. [Google Scholar] [CrossRef]
- Choe, J.Y.; Park, S.H.; Kim, S.K. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus. Lupus 2014, 23, 1486–1493. [Google Scholar] [CrossRef] [PubMed]
- Gottenberg, J.-E.; Seror, R.; Miceli-Richard, C.; Benessiano, J.; Devauchelle-Pensec, V.; Dieude, P.; Dubost, J.-J.; Fauchais, A.-L.; Goeb, V.; Hachulla, E.; et al. Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren’s syndrome. Data at enrollment in the prospective ASSESS cohort. PLoS ONE 2013, 8, e59868. [Google Scholar] [CrossRef] [PubMed]
- Theander, E.; Mandl, T. Primary Sjögren’s syndrome: Diagnostic and prognostic value of salivary gland ultrasonography using a simplified scoring system. Arthritis Care Res. 2014, 66, 1102–1107. [Google Scholar] [CrossRef] [PubMed]
- Thalayasingam, N.; Baldwin, K.; Judd, C.; Ng, W.F. New developments in Sjogren’s syndrome. Rheumatology 2021, 60 (Suppl. 6), VI53–VI61. [Google Scholar] [CrossRef]
- Negrini, S.; Emmi, G.; Greco, M.; Borro, M.; Sardanelli, F.; Murdaca, G.; Indiveri, F.; Puppo, F. Sjögren’s syndrome: A systemic autoimmune disease. Clin. Exp. Med. 2022, 22, 9–25. [Google Scholar] [CrossRef]
- Zhang, X.; Zhang, S.; He, J.; Hu, F.; Liu, H.; Li, J.; Zhu, J.; Li, Z. Ultrasonographic evaluation of major salivary glands in primary Sjögren’s syndrome: Comparison of two scoring systems. Rheumatology 2015, 54, 1680–1687. [Google Scholar] [CrossRef] [PubMed]
- Fidelix, T.; Czapkowski, A.; Azjen, S.; Andriolo, A.; Trevisani, V.F.M. Salivary gland ultrasonography as a predictor of clinical activity in Sjögren’s syndrome. PLoS ONE 2017, 12, e0182287. [Google Scholar] [CrossRef] [PubMed]
- Lee, K.A.; Lee, S.H.; Kim, H.R. Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjögren’s syndrome. Clin. Exp. Rheumatol. 2018, 36, S165–S172. [Google Scholar] [CrossRef]
- Milic, V.; Colic, J.; Cirkovic, A.; Stanojlovic, S.; Damjanov, N. Disease activity and damage in patients with primary Sjogren’s syndrome: Prognostic value of salivary gland ultrasonography. PLoS ONE 2019, 14, e0226498. [Google Scholar] [CrossRef] [PubMed]
- Yalcinkaya, Y.; Mumcu, G.; Özdemir, F.T.; Kuruş, R.E.; Ünal, A.U.; Direskeneli, H.; Bruyn, G.A.; Inanc, N. Are Salivary Gland Ultrasonography Scores Associated with Salivary Flow Rates and Oral Health-related Quality of Life in Sjögren Syndrome? J. Rheumatol. 2020, 47, 1774–1779. [Google Scholar] [CrossRef] [PubMed]
- Inanc, N.; Şahinkaya, Y.; Mumcu, G.; Özdemir, F.T.; Paksoy, A.; Ertürk, Z.; Direskeneli, H.; A Bruyn, G. Evaluation of salivary gland ultrasonography in primary Sjögren’s syndrome: Does it reflect clinical activity and outcome of the disease? Clin. Exp. Rheumatol. 2019, 37, S140–S145. [Google Scholar]
- Callegher, S.Z.; Zabotti, A.; Giovannini, I.; Treppo, E.; Quartuccio, L.; De Vita, S. Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren’s Syndrome. Front. Med. 2020, 7, 602354. [Google Scholar] [CrossRef]
- Coiffier, G.; Martel, A.; Albert, J.-D.; Lescoat, A.; Bleuzen, A.; Perdriger, A.; De Bandt, M.; Maillot, F. Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: Are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren’s syndrome? Ann. Rheum. Dis. 2021, 80, e111. [Google Scholar] [CrossRef] [PubMed]
- Zhang, X.; Feng, R.; Zhao, J.; Wang, Y.; He, J.; Liu, L.; Cheng, Y.; Yao, H.; Tang, S.; Chen, J.; et al. Salivary gland ultrasonography in primary Sjögren’s syndrome from diagnosis to clinical stratification: A multicentre study. Arthritis Res. Ther. 2021, 23, 1–9. [Google Scholar] [CrossRef]
- Delli, K.; van Ginkel, M.S.; Vissink, A.; Stel, A.J.; van der Vegt, B.; Spijkervet, F.K.; Kroese, F.G.; Arends, S.; Bootsma, H. Can salivary gland ultrasonography replace salivary gland biopsy in the diagnosis of Sjögren’s syndrome? Clin. Exp. Rheumatol. 2022, 40, 2443–2449. [Google Scholar] [CrossRef] [PubMed]
- Shiboski, C.H.; Shiboski, S.C.; Seror, R.; Criswell, L.A.; Labetoulle, M.; Lietman, T.M.; Rasmussen, A.; Scofield, H.; Vitali, C.; Bowman, S.J.; et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 2017, 69, 35–45. [Google Scholar] [CrossRef]
- Giovelli, R.A.; Santos, M.C.S.; Serrano, É.V.; Valim, V. Clinical characteristics and biopsy accuracy in suspected cases of Sjögren’s syndrome referred to labial salivary gland biopsy. BMC Musculoskelet. Disord. 2015, 16, 30. [Google Scholar] [CrossRef] [PubMed]
Parameter | pSS Patients | Control Group | p Value |
---|---|---|---|
Number of patients | 112 | 56 | 0.187 |
Females 74 (66.07%) | Females 36 (64.28%) | ||
Males 38 (33.92%) | Males 20 (35.71%) | ||
Mean age (years) | 55.5 ± 7.1 | 54.2 ± 5.9 | 0.197 |
Disease duration (years) | 7.6 ± 3.9 | - | - |
Medication used by SS patients | - | - | |
Hydroxychloroquine | 88 patients | ||
Azathioprine | 43 patients | ||
Mycophenolate mofetil | 45 patients | ||
Cyclophosphamide | 12 patients | ||
Corticoids | 68 patients |
Parameter | pSS Patients | Control Group | p-Value |
---|---|---|---|
Focus score | 4.03 ± 1.60 | - | - |
ESSDAI | 12.08 ± 7.53 | - | - |
Anti-SSA abs. | 85.41 ± 56.43 | - | - |
Anti-SSB abs. | 65.65 ± 54.88 | - | - |
TNF-α (pg/mL) | 27.82± 17.78 | 7.80 ± 4.74 | <0.001 |
IL6 (pg/mL) | 32.68 ± 15.14 | 6.79 ± 5.12 | <0.001 |
β2-Microglobulin (mg/L) | 3.39 ± 1.02 | 1.92 ± 0.46 | <0.01 |
Leukocytes/mmc | 3083.75 ± 1101.01 | 7586.94 ± 1227.08 | <0.001 |
Lymphocytes/mmc | 749.56 ± 368.51 | 2224.01 ± 419.34 | <0.001 |
Parameter | r | p |
---|---|---|
TNF-α | −0.68126 | <0.001 |
IL-6 | −0.78466 | <0.001 |
Β2-Microglobulin | −0.84076 | <0.001 |
Focus score | −0.82271 | <0.001 |
SGUS | −0.68002 | <0.001 |
ESSDAI | −0.88205 | <0.001 |
Parameter | r | p |
---|---|---|
Salivary flow rate | −0.68002 | <0.001 |
TNF-α | 0.59253 | <0.001 |
IL-6 | 0.73536 | <0.001 |
β2-microglobulin | 0.73417 | <0.001 |
Focus score | 0.76661 | <0.001 |
ESSDAI | 0.79405 | <0.001 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Caraba, A.; Roman, D.; Crișan, V.; Iurciuc, S.; Iurciuc, M. Salivary Flow Rate in Patients with Sjögren’s Syndrome: Correlations with Salivary Gland Ultrasound Findings and Biomarkers of Disease Activity. Int. J. Mol. Sci. 2025, 26, 101. https://doi.org/10.3390/ijms26010101
Caraba A, Roman D, Crișan V, Iurciuc S, Iurciuc M. Salivary Flow Rate in Patients with Sjögren’s Syndrome: Correlations with Salivary Gland Ultrasound Findings and Biomarkers of Disease Activity. International Journal of Molecular Sciences. 2025; 26(1):101. https://doi.org/10.3390/ijms26010101
Chicago/Turabian StyleCaraba, Alexandru, Deiana Roman, Viorica Crișan, Stela Iurciuc, and Mircea Iurciuc. 2025. "Salivary Flow Rate in Patients with Sjögren’s Syndrome: Correlations with Salivary Gland Ultrasound Findings and Biomarkers of Disease Activity" International Journal of Molecular Sciences 26, no. 1: 101. https://doi.org/10.3390/ijms26010101
APA StyleCaraba, A., Roman, D., Crișan, V., Iurciuc, S., & Iurciuc, M. (2025). Salivary Flow Rate in Patients with Sjögren’s Syndrome: Correlations with Salivary Gland Ultrasound Findings and Biomarkers of Disease Activity. International Journal of Molecular Sciences, 26(1), 101. https://doi.org/10.3390/ijms26010101